![Rupert Haynes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Rupert Haynes is the founder of Avata Biosciences.
Former jobs include Chief Executive Officer at Quantum BioPharma Ltd. from 2018 to 2019, Director-Global Marketing at GW Pharmaceuticals Ltd., Head-Global Commercial Operations at Swedish Orphan Biovitrum AB, and Head-Global Strategy at Radius Health, Inc. from 2021 to 2023.
Aktive Positionen von Rupert Haynes
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Rupert Haynes
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01.10.2023 |
| QUANTUM BIOPHARMA LTD. | Vorstandsvorsitzender | 06.02.2019 |
| GW PHARMACEUTICALS PLC | Vertrieb & Marketing | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
FSD Pharma, Inc.
 FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
